Investment Analysts' Weekly Ratings Updates for Eli Lilly And Co
11/7/2018 - Eli Lilly And Co was given a new $106.00 price target on by analysts at Societe Generale. They now have a "hold" rating on the stock.
from Biotech News
11/7/2018 - Eli Lilly And Co was given a new $106.00 price target on by analysts at Societe Generale. They now have a "hold" rating on the stock.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments